Debt-to-equity of Singular Genomics Systems, Inc. from 31 Mar 2022 to 30 Sep 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Singular Genomics Systems, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 30 Sep 2024.
Singular Genomics Systems, Inc. Debt-to-equity for the quarter ending 30 Sep 2024 was 53%, a 70% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Singular Genomics Systems, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	53%	+22%	+70%	30 Sep 2024
Q2 2024	50%	+23%	+87%	30 Jun 2024
Q1 2024	42%	+17%	+69%	31 Mar 2024
Q4 2023	36%	+16%	+81%	31 Dec 2023
Q3 2023	31%	+16%	+109%	30 Sep 2023
Q2 2023	27%	+17%	+165%	30 Jun 2023
Q1 2023	25%	+19%	+330%	31 Mar 2023
Q4 2022	20%			31 Dec 2022
Q3 2022	15%			30 Sep 2022
Q2 2022	10%			30 Jun 2022
Q1 2022	6%			31 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.